Showing results (2091-2100 of 2,211) with videos related to

Sort By:
Pageof 222
American Journal of Epidemiology|September 7, 2012
The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall of 2009Saumil S Doshi, Kendra E Stauffer, Amy Parker Fiebelkorn, et al.
Plos One|July 27, 2018
The evaluation of Animal Bite Treatment Centers in the Philippines from a patient perspectiveAnna Charinna B Amparo, Sarah I Jayme, Maria Concepcion R Roces, et al.
Psychological Medicine|June 10, 2010
Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosisM Aas, P Dazzan, V Mondelli, et al.
Psychological Medicine|August 25, 2022
Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 reportMehri Sajjadian, Rudolf Uher, Keith Ho, et al.
Pediatrics|May 22, 2021
Clinical and Biochemical Markers of Risk in Uncomplicated Severe Acute MalnutritionTrenton Dailey-Chwalibóg, Michael Freemark, Michael Muehlbauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2020
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial CancerVicky Makker, Matthew H Taylor, Carol Aghajanian, et al.
Ecology|July 28, 2012
Plant growth rates and seed size: a re-evaluationLindsay A Turnbull, Christopher D Philipson, Drew W Purves, et al.
Schizophrenia Bulletin|June 9, 2025
Longitudinal Trajectories of Clinical Features in Community Youth With Recurrent Psychosis Spectrum Symptoms: Findings From the Philadelphia Neurodevelopmental CohortMonica E Calkins, Ellyn R Butler, Tyler M Moore, et al.
Journal of General Internal Medicine|March 16, 2016
Individual Versus Team-Based Financial Incentives to Increase Physical Activity: A Randomized, Controlled TrialMitesh S Patel, David A Asch, Roy Rosin, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysisAndrea B Apolo, John A Ellerton, Jeffrey R Infante, et al.
Pageof 222